The firm served as lead counsel on behalf of Oklahoma Medical Research Foundation in a patent infringement suit brought in the Northern District of Oklahoma against Alexion Pharmaceuticals. The patents related to complement-inhibition technology and their use in a drug marketed by Alexion to treat a rare, debilitating and life-threatening disease. After replacing OMRF’s previous counsel in the matter and soon after claim construction briefing was complete, we obtained a settlement. It included payment to our client as well as public acknowledgement that individuals affiliated with OMRF were the true inventors of the technology at issue.

Oklahoma Med. Research Found. v. Alexion Pharmaceuticals, Inc., No. 07-163 (N.D. Okla. filed Mar. 15, 2007).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Copyright litigation for the owner of the rights to the famous Dick and Jane reading primer
Represented the owner of the rights to the famous Dick and Jane reading primer, a Pearson Education subsidiary, in trademark and copyright litigation more
Breach of contract and breach of fiduciary duty for a large financial institution
The firm represented a large financial institution in defense of breach of contract and breach of fiduciary duty claims brought by another major bank more
Halted auction of GRAMMY Award for The National Academy of the Recording Arts & Sciences
Represented The National Academy of the Recording Arts & Sciences, the organization which administers the prestigious GRAMMY award ceremony, in more
Georgia-Pacific Corp. v. The Procter & Gamble Co.
Successfully represented Georgia-Pacific in the expedited arbitration of a case involving false advertising more